pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4742 |
Genomic Coordinates | chr1: 224398227 - 224398311 |
Description | Homo sapiens miR-4742 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4742-5p | ||||||||||||||||||||||||
Sequence | 1| UCAGGCAAAGGGAUAUUUACAGA |23 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZIC5 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | Zic family member 5 | ||||||||||||||||||||
Transcript | NM_033132 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZIC5 | |||||||||||||||||||||
3'UTR of ZIC5 (miRNA target sites are highlighted) |
>ZIC5|NM_033132|3'UTR 1 AATTTATTATTAATAATAATAAGTGAAATAATAAGTGGGAGTCCTTGGACCACATCCTAACCTGAGACAATGCCGAGCCT 81 GAGACAAACCCGTGACTCAGACTTGCCACCGGGTCTAATTAGCCCTATTTATTCAGTATGAAACCCTATGGTGTTTGTAC 161 ATTTAATTAATTTAATTAAGATATTTGGGCTTTTTTTTTTTTTTTTCTTAAAAAACAAACAAAAAACAACCAAGCTGGAC 241 TTGTACATTGCAGGAGGATGGGGCTGGGGGCAAATTGTACCAAGGAAAATGAATGGAGAGATTAGTTAATGGCGATACAC 321 ACTGCCGATGCAATATATATATATATATATATATACATATATATATATATTATTTTTTTTAAAAGGGGGAGAAAAAGAGC 401 ATTAAGTCAGAACTTAACACAGCACCAAGGCCCTCTGCATTTCCCAGAGTGCCTCTCAAATGCCTTTGACACCATACCAT 481 GGGCTGCTTTTGAGCCTCCTTGTTGGACCCTAATTCTGCCAAGGCCTCTTGATTGTAAACCACACACCTGCTGCATTGCC 561 AACAGATCCTGTTCCGTACCTGTGTCCAAAAACATTTGTAAAAACCCTTTGAGTTTAATATTTGTAATTTTTAATTTCCA 641 CTCTTTTATTACTGATCTTAGCTTAATACAATATTTTTATACAGGATTATTTCTTCAGTATCCTACTGTGTGATTTTAAA 721 AAAAGATGCAGCAACCTTAATATATCTCCATATCTTGTGCTACTGTGATTGTTCAAGCAAAAGTGGAGAGAAGAAAAGCT 801 GCTGCAAAAGACAACTGTGAAACTGTGATATTTTATAAAATAGAAGAAATTCAAGTGCTTTCTTTTTCCTATATGTTTTT 881 TTTTTTTTATCTGAATTCTCAGATACTGCCTCCTAACTGTGTCCAAACTTCTTGTGTAATAAAGAGATTCTGTTTTCGAT 961 CCTAAGTTCTTTGGGATGCCAACATTCACAGTCAAGTCTTGAGGAGGTGTGATGATGGCATCATGCCTATTTTTTTGGAA 1041 AGCTGTTGTTTTTAAAACAGGCCAACACCTCTTTTATACTGTTGTATCAGCCTTTTAAAAAGTCTATTTTTCAATGCCTG 1121 AAACTGCATTTTAATGCATTTTCTTCCACCTGAGCACTGAGCACACCAAACTGGAATCCATTTGAAAATGACAGTGTGTG 1201 AAGTGTATGATTTACATTAAAAGAGGGGAGGGAGTTGCCATACATATTAAAAATTTTTAAAAGGTTTATAGTTACCACCA 1281 AACACTGATGAATGTGTGACCTTTGCCAGAGCTGTCAAGCTAGGATAAAAAAGGTCAAGGACCTAGGACAATAACTCTTA 1361 GTCGATTTATTTTCGGTTGGTACAACACATCTCCTGTGCAAAATGTAGTCCATCAGAAACATCCTACAGATACACTAAAG 1441 AGCACTAATTTATCCTTAGAGACCCCGAAGACACCCCCTCCCCAGGGTTTGTAGAAATTTGTTTTGTGTGCTGTGAGTGG 1521 TTGATGTAGTCTTGTCATTGTTAATAACTTGTATGTGAACACTATTATTTGTACAGTTGAATTAATTTATTTTCAGACAT 1601 CATCCTTTTTTTTTTTCTTTCCTGGAAGAGTTCAAAGCACACCAAAGAATTATATTATACATTTTGGTGAAAGATTGTCA 1681 TTTATGATCCATGGTTTATTTAAAAAAAAAAGGAAAGAAAATGGAAAAATATATTTTTAAGCTTACTTGAATGAACAACG 1761 TAATGTGAAAACCAAGACTCTTCCTGCATGTCTTTTTTGCATTGTGTTGATAAGATTATATATAGTTTATAGATATATTA 1841 TATTACTAGTACAGTGCATGGTGCTGTCACTTGGAAAGCCTTTCAATGTTGTCTTCAGATTGTTGTGATGAATATGAAAC 1921 ATGCAGACCCTCCTTTATAAAGAAAAAGACCTTAAAACTTGAATATGAGATAATTTTACATTTTAAAAGTTTATTTGATT 2001 TTCATATTATTCACTTTCAAAGCCCTTTCAAATAGAAAAGGTATGAACTTTTGGGGGGATAATTTATGTATCGTAAACTT 2081 ATTAGAACAAAATATTCCTGATGTATAATGAGTTGTTTTATTTATACAACTTTTTCAATGGTAGTTTGCACTATTCTTTA 2161 TTATGCTACAGGTTTATTTATTATGAAACAAAGGAATATGTATTTTATGTATTTTACCATGCATAGGTTAACTCTTTGCC 2241 ACAGATTTATTGGTTCTTGATACACCTAAAATAAAAAAAAATGTGTACCTCCAATAGAGAGCAAGCAAGAATGATTATGA 2321 AGTAACAAATTTAATAAAGGTATTCTTGTTATTATTGCTTATGTTTTACATAATGGCATATCTCTCATACAAATAGAACA 2401 GGTTGCTAATGGAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000267294.4 | 3UTR | UAUUUUUCAAUGCCUGAAACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000267294.4 | 3UTR | AAACUGCAUUUUAAUGCAUUUUCUUCCACCUGAGCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
70 hsa-miR-4742-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT065632 | CLIC4 | chloride intracellular channel 4 | 2 | 4 | ||||||||
MIRT068170 | TXLNA | taxilin alpha | 2 | 2 | ||||||||
MIRT119024 | TSN | translin | 2 | 2 | ||||||||
MIRT165212 | GRAMD3 | GRAM domain containing 2B | 2 | 2 | ||||||||
MIRT175254 | PSAT1 | phosphoserine aminotransferase 1 | 2 | 4 | ||||||||
MIRT213228 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT296337 | PARD6B | par-6 family cell polarity regulator beta | 2 | 2 | ||||||||
MIRT316776 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT453943 | XRCC6 | X-ray repair cross complementing 6 | 2 | 6 | ||||||||
MIRT454599 | RPL13A | ribosomal protein L13a | 2 | 2 | ||||||||
MIRT458485 | RMI1 | RecQ mediated genome instability 1 | 2 | 6 | ||||||||
MIRT458650 | SGPP2 | sphingosine-1-phosphate phosphatase 2 | 2 | 2 | ||||||||
MIRT459240 | ADRBK1 | G protein-coupled receptor kinase 2 | 2 | 2 | ||||||||
MIRT461008 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT462026 | RIF1 | replication timing regulatory factor 1 | 2 | 2 | ||||||||
MIRT462103 | TMEM214 | transmembrane protein 214 | 2 | 2 | ||||||||
MIRT463255 | ZIC5 | Zic family member 5 | 2 | 4 | ||||||||
MIRT465190 | TRPS1 | transcriptional repressor GATA binding 1 | 2 | 2 | ||||||||
MIRT470507 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 2 | 2 | ||||||||
MIRT472356 | TSPAN1 | tetraspanin 1 | 2 | 2 | ||||||||
MIRT473260 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT477527 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 4 | ||||||||
MIRT485182 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 4 | ||||||||
MIRT486461 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT492760 | PER1 | period circadian clock 1 | 2 | 8 | ||||||||
MIRT496703 | TRIM39 | tripartite motif containing 39 | 2 | 2 | ||||||||
MIRT497227 | MORC2 | MORC family CW-type zinc finger 2 | 2 | 2 | ||||||||
MIRT499582 | INTU | inturned planar cell polarity protein | 2 | 4 | ||||||||
MIRT504081 | C9orf40 | chromosome 9 open reading frame 40 | 2 | 6 | ||||||||
MIRT505484 | SRSF2 | serine and arginine rich splicing factor 2 | 2 | 2 | ||||||||
MIRT513255 | FBXO17 | F-box protein 17 | 2 | 2 | ||||||||
MIRT525061 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT528798 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT534357 | SFT2D2 | SFT2 domain containing 2 | 2 | 2 | ||||||||
MIRT538731 | CAPN1 | calpain 1 | 2 | 2 | ||||||||
MIRT550792 | WARS2 | tryptophanyl tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT553994 | SRPR | SRP receptor alpha subunit | 2 | 4 | ||||||||
MIRT568102 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT570107 | SLC18B1 | solute carrier family 18 member B1 | 2 | 2 | ||||||||
MIRT570823 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT572004 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT572352 | PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 2 | 2 | ||||||||
MIRT609716 | TMEM132C | transmembrane protein 132C | 2 | 2 | ||||||||
MIRT613982 | LRRC40 | leucine rich repeat containing 40 | 2 | 2 | ||||||||
MIRT620740 | CCL16 | C-C motif chemokine ligand 16 | 2 | 2 | ||||||||
MIRT625074 | C15orf41 | chromosome 15 open reading frame 41 | 2 | 4 | ||||||||
MIRT627941 | NNT | nicotinamide nucleotide transhydrogenase | 2 | 2 | ||||||||
MIRT629941 | IGSF6 | immunoglobulin superfamily member 6 | 2 | 2 | ||||||||
MIRT633396 | FBXW8 | F-box and WD repeat domain containing 8 | 2 | 2 | ||||||||
MIRT635846 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT638086 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT643996 | TCHP | trichoplein keratin filament binding | 2 | 2 | ||||||||
MIRT660020 | C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT660161 | BRCC3 | BRCA1/BRCA2-containing complex subunit 3 | 2 | 2 | ||||||||
MIRT668887 | CSRP1 | cysteine and glycine rich protein 1 | 2 | 2 | ||||||||
MIRT676729 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT677210 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT685949 | PTGIS | prostaglandin I2 synthase | 2 | 2 | ||||||||
MIRT687816 | ITPRIPL2 | inositol 1,4,5-trisphosphate receptor interacting protein like 2 | 2 | 2 | ||||||||
MIRT689900 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT698214 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT698279 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT698758 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT698789 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT703152 | GPR137C | G protein-coupled receptor 137C | 2 | 2 | ||||||||
MIRT704408 | CTPS1 | CTP synthase 1 | 2 | 2 | ||||||||
MIRT705067 | C4orf32 | family with sequence similarity 241 member A | 2 | 2 | ||||||||
MIRT710201 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT714495 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT720082 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|